Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
BioViotica
Pentabromopseudilin
190
CHF
CHF 190.00
In stock
BVT-0441-C500500 µgCHF 190.00
BVT-0441-M0011 mgCHF 335.00
Product Details | |
---|---|
Synonyms | PBP; Pentabrompseudilin; NSC641543; NSC288032; PBQ; 2-(3,5-Dibromo-2-hydroxyphenyl)-3,4,5-tribromopyrrol; 2,4-Dibromo-6-(3,4,5-tribromo-1H-pyrrol-2-yl)phenol |
Product Type | Chemical |
Properties | |
Formula |
C10H4Br5NO |
MW | 553.7 |
CAS | 10245-81-5 |
RTECS | SK8150000 |
Source/Host Chemicals | Isolated from sea water proteobacteria Alteromonas Iuteo-violaceus. |
Purity Chemicals | ≥98% (HPLC) |
Appearance | Off-white powder. |
Solubility | Soluble in DMSO (5mg/ml), acetone, butanol, ethylacetate or diethylether. |
Identity | Determined by 1H-NMR. |
Declaration | Manufactured by BioViotica. |
InChi Key | LXMNWKJHYOZUQL-UHFFFAOYSA-N |
Smiles | OC1=C(Br)C=C(Br)C=C1C1=C(Br)C(Br)=C(Br)N1 |
Shipping and Handling | |
Shipping | BLUE ICE |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice |
Keep cool and dry. Protect from light. |
Use/Stability |
Stable for at least 1 year after receipt when stored at -20°C. Store solutions at -20°C in the dark. |
Documents | |
MSDS | Download PDF |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
- Antibiotic [1, 2, 4, 6].
- Antibacterial, cytotoxic, herbicidal and antimalarial compound [3, 9, 11, 13].
- Human lipoxygenase inhibitor [7].
- Potent myosin ATPase inhibitor [8, 10, 14].
- Inhibitor of the non-mevalonate pathway enzyme IspD [13].
Product References
- Production of a pyrrole antibiotic by a marine bacterium: P.R. Burkholder, et al.; Appl. Microbiol. 14, 649 (1966)
- The structure of a bromine-rich marine antibiotic: F.M. Lovell; JACS 88, 4510 (1966)
- Marine bacteria. I. Synthesis of pentabromopseudilin, a cytotoxic phenylpyrrole from Alteromonas luteoviolaceus: H. Laatsch & H. Pudleiner; Liebigs Ann. Chem. 9, 863 (1989)
- Biosynthesis of the marine antibiotic pentabromopseudilin. Part 1. The benzene ring: U. Hanefeld, et al.; J. Org. Chem. 8, 847 (1993)
- Structure-activity relationships of phenyl- and benzoylpyrroles: H. Laatsch, et al.; Chem. Pharm. Bull. 43, 537 (1995)
- Biosynthesis of the marine antibiotic pentabromopseudilin. Part 2. The pyrrole ring: J. Peschke, et al.; Biosci. Biotechnol. Biochem. 69, 628 (2005)
- A rev(V)-catalysed C-N bond-forming route to human lipoxygenase inhibitors: O. Rachana, et al.; Org. Lett. 7, 2501 (2005)
- The mechanism of pentabromopseudilin inhibition of myosin motor activity: R. Fedorov, et al.; Nat. Struct. Mol. Biol. 16, 80 (2009)
- Highly brominated antimicrobial metabolites from a marine Pseudoalteromonas sp.: D. Feher, et al.; J. Nat. Prod. 73, 1963 (2010)
- Inhibition of myosin ATPase activity by halogenated pseudilins: a structure-activity study: M. Preller, et al.; J. Med. Chem. 54, 3675 (2011)
- Agrochemicals against malaria, sleeping sickness, leishmaniasis and chagas Disease: M. Witschel, et al.; PLoS Negl. Trop. Dis. 6, 1805 (2012)
- Small-molecule inhibitors of myosin proteins: L.M. Bond, et al.; Future Med. Chem. 5, 41 (2013)
- Toxicity of bioactive and probiotic marine bacteria and their secondary metabolites in Artemia sp. and Caenorhabditis elegans as eukaryotic model organisms: A.K. Neu, et al.; Appl. Environ. Microbiol. 80, 146 (2014)
- Pseudilins: halogenated, allosteric inhibitors of the non-mevalonate pathway enzyme IspD: A. Kunfermann, et al.; Angew. Chem. Int. Ed. Engl. 53, 2235 (2014)
- Myosin-II-mediated cell shape changes and cell intercalation contribute to primitive streak formation: E. Rozbicki, et al.; Nat. Cell Biol. 17, 397 (2015)
- Actomyosin and CSI1/POM2 cooperate to deliver cellulose synthase from Golgi to cortical microtubules in Arabidopsis: L. Liu, et al.; Nature Commun. 14, 7442 (2023)